Stocktoria

ELITE PHARMACEUTICALS INC /NV/ ELTP

OTC · stock · Pharmaceutical Preparations · website · IPO 2014-02-20

ELITE PHARMACEUTICALS INC /NV/ statistics & valuation

Market cap$425.4M
P / E9.5×
P / S2.9×
P / B4.3×
P / FCF18.6×
Net margin30.1%
Return on equity45.4%
FCF margin15.3%
Return on capital40.6%
Graham number -32.7%$0.24

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($0.24); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
39.50% -49.20% -122.60% -12.50% 20.00% 27.60% 10.40% 35.50% -5.10% 30.10% 2017201820192020202120222023202420252026
Gross margin (%)
38.80% 52.90% 37.90% 44.30% 46.80% 45.90% 48.60% 46.50% 47.70% 50.40% 2017201820192020202120222023202420252026
Operating margin (%)
-76.30% -121.40% -121.00% -12.70% 8.30% 15.70% 10.80% 19.10% 23.30% 33.00% 2017201820192020202120222023202420252026
Return on equity (%)
14.90% -80.30% -21.00% 31.50% 35.30% 12.30% 34.90% -8.10% 45.40% 2017201820192020202120222023202420252026
Shares outstanding
927.9M 802.5M 824.8M 993.3M 1.01B 1.01B 1.01B 1.07B 1.07B 1.14B 2017201820192020202120222023202420252026
Net debt ($)
$443272 -$1.7M -$7.3M 2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
11.10% -11.90% -38.00% -9.00% 19.40% 25.30% 8.70% 24.00% -4.50% 32.40% 2017201820192020202120222023202420252026
Free cash flow margin (%)
18.60% -7.00% -7.10% 6.90% 15.30% 2017201820192020202120222023202420252026
Debt / equity (×)
0.15× 0.09× 0.05× 2017201820192020202120222023202420252026
EPS ($)
-$0.01 -$0.01 -$0.01 $0.00 $0.00 $0.01 $0.00 $0.02 $0.00 $0.03 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin50.4%47.7%46.5%48.6%45.9%46.8%44.3%37.9%52.9%38.8%
Operating margin33.0%23.3%19.1%10.8%15.7%8.3%-12.7%-121.0%-121.4%-76.3%
Net margin30.1%-5.1%35.5%10.4%27.6%20.0%-12.5%-122.6%-49.2%39.5%
FCF margin15.3%6.9%-7.1%-7.0%18.6%—————
Return on assets32.4%-4.5%24.0%8.7%25.3%19.4%-9.0%-38.0%-11.9%11.1%
Return on equity45.4%-8.1%34.9%12.3%35.3%31.5%-21.0%370.0%-80.3%14.9%
Debt / equity————0.05×0.09×0.15×———
Current ratio6.454.883.072.752.822.101.191.282.685.50

Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.